RIVERHEAD CAPITAL MANAGEMENT LLC - CYTOKINETICS INC ownership

CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 141 filers reported holding CYTOKINETICS INC in Q4 2019. The put-call ratio across all filers is 1.74 and the average weighting 0.2%.

Quarter-by-quarter ownership
RIVERHEAD CAPITAL MANAGEMENT LLC ownership history of CYTOKINETICS INC
ValueSharesWeighting
Q3 2019$131,000
+1.6%
11,5000.0%0.01%0.0%
Q2 2019$129,000
+38.7%
11,5000.0%0.01%
+25.0%
Q1 2019$93,000
+89.8%
11,500
+49.4%
0.00%
+100.0%
Q4 2018$49,000
+2.1%
7,700
+57.1%
0.00%0.0%
Q3 2018$48,000
+118.2%
4,900
+88.5%
0.00%
+100.0%
Q2 2018$22,0002,6000.00%
Other shareholders
CYTOKINETICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
BVF INC/IL 5,721,888$41,198,0004.18%
Virtus ETF Advisers LLC 93,309$672,0000.58%
IRONWOOD INVESTMENT MANAGEMENT LLC 105,324$758,0000.55%
LANSDOWNE PARTNERS (UK) LLP 2,647,981$19,065,0000.20%
WASATCH ADVISORS LP 1,761,882$12,686,0000.16%
PINNACLE ASSOCIATES LTD 888,415$6,397,0000.12%
ESSEX INVESTMENT MANAGEMENT CO LLC 84,690$610,0000.08%
Birchview Capital, LP 10,000$72,0000.05%
Piermont Capital Management Inc. 16,530$119,0000.04%
Tekla Capital Management LLC 137,797$992,0000.04%
View complete list of CYTOKINETICS INC shareholders